New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Cytosorbents Corporation (CTSO) vs CVRx, Inc. (CVRX)
- Cytosorbents Corporation CTSO 5.26 −5.57%
- CVRx, Inc. CVRX 0.53 −11.67%
Cytosorbents Corporation and CVRx, Inc. are both Medical Devices companies. Cytosorbents Corporation and CVRx, Inc. are of similar size ($17.5M and $17.2M). CVRx, Inc. grew revenue faster over the last twelve months: 7.79% against 3.07%. Cytosorbents Corporation has the higher net margin (−48.9% vs −88.3%) and the higher return on invested capital (−66.9% vs −225.0%). Across the 17 metrics below, Cytosorbents Corporation leads on 10 and CVRx, Inc. on 7.
Valuation
Profitability
| Metric | CTSO | CVRX | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.61% | 86.90% | 58.08% |
| Operating margin | (34.74%) | (81.90%) | (17.17%) |
| Net margin | (48.94%) | (88.28%) | (16.35%) |
| Free cash flow margin | (25.32%) | (69.69%) | (6.21%) |
| Return on equity | (336.17%) | (172.17%) | (21.47%) |
| Return on assets | (42.38%) | (53.55%) | (17.83%) |
| Return on invested capital | (66.90%) | (224.98%) | (8.54%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack